“cancer” Archives

in
Entry Author Date Location
Jazz Pharma, ImmunoGen Strike Up Drug Pact in Leukemia and More 08/29/17 Boston
UT Nominates MD Anderson Alum Peter Pisters to Replace DePinho 08/25/17 Texas
On Drug Pricing: FDA Backs Up Its Calls for Increased Competition 08/21/17 San Diego
Latest Immunotherapy Setback: Bristol Drugs Stumble in Kidney Cancer 08/16/17 New York
Startup Builders, IPO Closers & More: Meet Xconomy’s CEO Award Finalists 08/10/17 Boston
Experimental Drug With San Antonio Roots Changes Home After Merger 08/08/17 Texas
New Rapamycin CEO Hired to Handle Funding, FDA Inflection Points 08/07/17 Texas
San Antonio Biomedical Group Awards Miami Healthcare Researcher 08/02/17 Texas
Invitae Expands Gene Test Menu With Good Start, CombiMatrix Deals 07/31/17 San Francisco
Tesaro Cashes In Again on PARP Blocker With $100M Takeda Deal 07/27/17 Boston
Immunotherapy Shakeup: AstraZeneca Inks Merck Deal as Drug Combo Fails 07/27/17 National
Effector Raises $38.6M to Advance New Class of Anti-Cancer Drugs 07/25/17 San Diego
Merck Drug Shows No Life-Extending Benefit in Head-and-Neck Cancer 07/24/17 Boston
Bio Roundup: Obamacare Persists, FDA Approves, Vertex Wows & More 07/21/17 National
A.I. Prizes, Coming to Healthcare, Hit $1M Mark in Cancer Contests 07/20/17 National
Bio Roundup: PDUFA Progress, BCRA Redux, CAR-T Thumbs Up, & More 07/14/17 National
Unanimous Advice To FDA: Approve Landmark CAR-T Cancer Therapy 07/12/17 National
Roundup: LiveOak, Memorial Hermann, AT&T, March Capital, & DigniCap 07/10/17 Texas
Bio Roundup: BCRA Fireworks, Shkreli Muzzled, Endo Pulls Drug & More 07/07/17 National
Celgene Builds Up Cancer Drug Pipeline With BeiGene Deal 07/06/17 New York
FDA Halts Merck’s Multiple Myeloma Trials After Patient Deaths 07/05/17 New York
Bio Roundup: Senate Drama, A.I. Stories, Data Dives, Shkreli & More 06/30/17 National
Vivace Therapeutics Comes Out of Stealth With $25M for Cancer Drugs 06/28/17 San Francisco
Startup Founder’s Quest for Cure Leads to Genomics Hackathon at Google 06/23/17 San Francisco
Repare Nabs $68M To Find Synthetic Lethal Cancer Targets Beyond PARP 06/22/17 Boston
New Ovarian Cancer Data Suggests Larger Role For Top Clovis Drug 06/19/17 Boulder/Denver
Checkmate Pharma Clinches $27M for More Studies in Skin Cancer 06/15/17 Boston
UT Health Cancer Center Hires Rare Blood Cancer Expert as Director 06/15/17 Texas
Athenex IPO Raises $66M to Fund Clinical Trials for Cancer Drugs 06/14/17 New York
In a Myeloma Setback, Merck Halts Studies Due to Patient Deaths 06/12/17 New York
Page 2 of 69 « previous page · next page »